Singulex launched this week its new Erenna Interleuken-17A/F immunoassay research kit.
The kit adds to the company's TH17 pathway bioassay collection. IL-17A, IL-17F, and IL-17A/F have been implicated in autoimmune diseases including rheumatoid arthritis and multiple sclerosis.
The assays are optimized for use on Singulex's Erenna Immunoassay System, which enables detection at the single molecule level, the company said.